GL
ACOR

GLG LLC’s Acorda Therapeutics ACOR Stock Holding History

GLG LLC’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-464
Closed -$1.85M – 684
2015
Q1 		$1.85M Sell
464
-386
-45% -$1.77M 0.05% 337
2014
Q4 		$4.17M Hold
850
– – 0.12% 201
2014
Q3 		$3.46M Buy
+850
New +$3.19M 0.09% 274

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GLG LLC's ACOR Position: Q2 2015 in Review

GLG LLC sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 464 shares — an estimated $1.85M sold.

GLG LLC first reported a position in ACOR in Q3 2014 and held it in 3 quarters. The position peaked at $4.17M in Q4 2014. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • GLG LLC reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
  • GLG LLC sold 464 Acorda Therapeutics shares in Q2 2015, an estimated $1.85M.
  • GLG LLC first reported a position in Acorda Therapeutics in Q3 2014 and held it in 3 quarters.
  • GLG LLC's Acorda Therapeutics position peaked at $4.17M in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on GLG LLC's 13F filing for Q2 2015, filed 14 Aug 2015.